Kinnate Biopharma Inc.
KNTE · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$17 | -$31 | -$32 | -$33 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$8 | $4 | $4 | $0 |
| Stock-Based Comp. | $4 | $5 | $5 | $5 |
| Change in WC | -$3 | $1 | -$2 | $0 |
| Other Non-Cash | $7 | -$5 | -$5 | -$1 |
| Operating Cash Flow | -$17 | -$26 | -$29 | -$28 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | -$0 |
| Net Acquisitions | -$9 | $0 | $0 | -$0 |
| Inv. Purchases | -$19 | -$29 | -$73 | -$33 |
| Inv. Sales/Matur. | $42 | $72 | $62 | $89 |
| Other Inv. Act. | $0 | $0 | -$0 | $0 |
| Investing Cash Flow | $14 | $43 | -$11 | $55 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $9 | $0 | $1 | -$9 |
| Financing Cash Flow | $9 | $0 | $1 | -$9 |
| Forex Effect | $0 | -$12 | $44 | $0 |
| Net Chg. in Cash | $5 | $17 | -$39 | $19 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $52 | $35 | $74 | $55 |
| End Cash | $57 | $52 | $35 | $74 |
| Free Cash Flow | -$17 | -$26 | -$29 | -$28 |